Cargando…
Development of a Dendritic Cell/Tumor Cell Fusion Cell Membrane Nano-Vaccine for the Treatment of Ovarian Cancer
Ovarian cancer (OC) is a malignant tumor that seriously affects women’s health. In recent years, immunotherapy has shown great potential in tumor treatment. As a major contributor of immunotherapy, dendritic cells (DCs) - based tumor vaccine has been demonstrated to have a positive effect in inducin...
Autores principales: | Zhang, Lei, Zhao, Wei, Huang, Jinke, Li, Fangxuan, Sheng, Jindong, Song, Hualin, Chen, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893350/ https://www.ncbi.nlm.nih.gov/pubmed/35251013 http://dx.doi.org/10.3389/fimmu.2022.828263 |
Ejemplares similares
-
Dendritic Cell Vaccines in Ovarian Cancer
por: Zhang, Xi, et al.
Publicado: (2021) -
Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition
por: Zhang, Lei, et al.
Publicado: (2019) -
Dendritic Cell Vaccination, Immune Regulation, and Clinical Outcomes in Ovarian Cancer
por: Goyne, Hannah E., et al.
Publicado: (2013) -
Dendritic Cell-Targeted Vaccines
por: Cohn, Lillian, et al.
Publicado: (2014) -
Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors
por: Bulgarelli, Jenny, et al.
Publicado: (2019)